796 related articles for article (PubMed ID: 447482)
1. Establishment and characterization of a human prostatic carcinoma cell line (PC-3).
Kaighn ME; Narayan KS; Ohnuki Y; Lechner JF; Jones LW
Invest Urol; 1979 Jul; 17(1):16-23. PubMed ID: 447482
[TBL] [Abstract][Full Text] [Related]
2. Chromosomal analysis of human prostatic adenocarcinoma cell lines.
Ohnuki Y; Marnell MM; Babcock MS; Lechner JF; Kaighn ME
Cancer Res; 1980 Mar; 40(3):524-34. PubMed ID: 7471073
[TBL] [Abstract][Full Text] [Related]
3. Heterotransplantation of a human prostatic adenocarcinoma cell line in nude mice.
Mickey DD; Stone KR; Wunderli H; Mickey GH; Vollmer RT; Paulson DF
Cancer Res; 1977 Nov; 37(11):4049-58. PubMed ID: 908039
[TBL] [Abstract][Full Text] [Related]
4. Establishment and characterization of a cell line (CUMC-3) derived from a human squamous carcinoma of the uterine cervix.
Kim JW; Cho YH; Lyu MS; Lee CG; Jung JK; Kim SJ; Namkoong SE
Gynecol Oncol; 1995 Apr; 57(1):47-60. PubMed ID: 7705700
[TBL] [Abstract][Full Text] [Related]
5. Establishment and characterization of a human primary prostatic adenocarcinoma cell line (ND-1).
Narayan P; Dahiya R
J Urol; 1992 Nov; 148(5):1600-4. PubMed ID: 1279221
[TBL] [Abstract][Full Text] [Related]
6. New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis.
Tian J; Tang ZY; Ye SL; Liu YK; Lin ZY; Chen J; Xue Q
Br J Cancer; 1999 Nov; 81(5):814-21. PubMed ID: 10555751
[TBL] [Abstract][Full Text] [Related]
7. The Src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer.
Xia W; Unger P; Miller L; Nelson J; Gelman IH
Cancer Res; 2001 Jul; 61(14):5644-51. PubMed ID: 11454719
[TBL] [Abstract][Full Text] [Related]
8. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice.
Pettaway CA; Pathak S; Greene G; Ramirez E; Wilson MR; Killion JJ; Fidler IJ
Clin Cancer Res; 1996 Sep; 2(9):1627-36. PubMed ID: 9816342
[TBL] [Abstract][Full Text] [Related]
9. LNCaP model of human prostatic carcinoma.
Horoszewicz JS; Leong SS; Kawinski E; Karr JP; Rosenthal H; Chu TM; Mirand EA; Murphy GP
Cancer Res; 1983 Apr; 43(4):1809-18. PubMed ID: 6831420
[TBL] [Abstract][Full Text] [Related]
10. Morphological, biological, and biochemical characteristics of a benign human trichilemmoma cell line in vivo and in vitro.
Kanzaki T; Eto H; Umezawa A; Maeda T; Iwase H; Ito M
Cancer Res; 1981 Jun; 41(6):2468-75. PubMed ID: 6165463
[TBL] [Abstract][Full Text] [Related]
11. Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells.
Gao J; Arnold JT; Isaacs JT
Cancer Res; 2001 Jul; 61(13):5038-44. PubMed ID: 11431338
[TBL] [Abstract][Full Text] [Related]
12. Establishment and characterization of a new human prostatic cancer cell line: DuCaP.
Lee YG; Korenchuk S; Lehr J; Whitney S; Vessela R; Pienta KJ
In Vivo; 2001; 15(2):157-62. PubMed ID: 11317521
[TBL] [Abstract][Full Text] [Related]
13. Biochemical, cytogenetic, and morphological characteristics of human primary and metastatic prostate cancer cell lines.
Dahiya R; Yoon WH; Boyle B; Schoenberg S; Yen TS; Narayan P
Biochem Int; 1992 Aug; 27(4):567-77. PubMed ID: 1417893
[TBL] [Abstract][Full Text] [Related]
14. Establishment of a novel human dedifferentiated liposarcoma cell line, FU-DDLS-1: conventional and molecular cytogenetic characterization.
Nishio J; Iwasaki H; Ishiguro M; Ohjimi Y; Fujita C; Ikegami H; Ariyoshi A; Naito M; Kaneko Y; Kikuchi M
Int J Oncol; 2003 Mar; 22(3):535-42. PubMed ID: 12579306
[TBL] [Abstract][Full Text] [Related]
15. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
Tso CL; McBride WH; Sun J; Patel B; Tsui KH; Paik SH; Gitlitz B; Caliliw R; van Ophoven A; Wu L; deKernion J; Belldegrun A
Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142
[TBL] [Abstract][Full Text] [Related]
16. Blockade of epidermal growth factor receptor signaling in tumor cells and tumor-associated endothelial cells for therapy of androgen-independent human prostate cancer growing in the bone of nude mice.
Kim SJ; Uehara H; Karashima T; Shepherd DL; Killion JJ; Fidler IJ
Clin Cancer Res; 2003 Mar; 9(3):1200-10. PubMed ID: 12631626
[TBL] [Abstract][Full Text] [Related]
17. Studies on carcinogenesis of human prostate. IV. Comparison of normal and neoplastic prostate during long-term explant culture.
Heatfield BM; Sanefuji H; Trump BF
Scan Electron Microsc; 1979; (3):645-56. PubMed ID: 524030
[TBL] [Abstract][Full Text] [Related]
18. [Studies of the origin of malignant rhabdoid tumor(MRT)--experimental researches on the MRT evolving in nude mice inoculated with violently variable HeLa cells].
Zhang DL; Huang GS; Li LJ; He XY; Xia GT; Gao BX; Bai XH; Liu SG
Yi Chuan Xue Bao; 2000; 27(12):1057-71. PubMed ID: 11209698
[TBL] [Abstract][Full Text] [Related]
19. The human Y chromosome suppresses the tumorigenicity of PC-3, a human prostate cancer cell line, in athymic nude mice.
Vijayakumar S; Garcia D; Hensel CH; Banerjee M; Bracht T; Xiang R; Kagan J; Naylor SL
Genes Chromosomes Cancer; 2005 Dec; 44(4):365-72. PubMed ID: 16080199
[TBL] [Abstract][Full Text] [Related]
20. Malignant transformation in a nontumorigenic human prostatic epithelial cell line.
Hayward SW; Wang Y; Cao M; Hom YK; Zhang B; Grossfeld GD; Sudilovsky D; Cunha GR
Cancer Res; 2001 Nov; 61(22):8135-42. PubMed ID: 11719442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
